selected publications
-
Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.
Anesthesiology.
2016
Academic Article
GET IT
Times cited: 12 -
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat.
Anesthesiology.
2016
Academic Article
GET IT
Times cited: 9 -
Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.
Anesthesiology.
2010
Academic Article
GET IT
Times cited: 28 -
Fumarates: unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine.
Journal of critical care.
2009
Review
GET IT
Times cited: 22